Difference between revisions of "BRST5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(6 intermediate revisions by the same user not shown) | |||
Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
− | + | __TOC__ | |
<br /> | <br /> | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
Line 19: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
− | |CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST) | + | | |
+ | ====CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST)==== | ||
| | | | ||
---- | ---- | ||
Line 121: | Line 122: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | !'''Disease''' | ||
+ | !'''Page Type''' | ||
+ | !'''<span style="color:#0070C0">Author''' | ||
+ | !'''Date Assigned to Author''' | ||
+ | !'''Target Completion Date''' | ||
+ | !'''Author Content (Pending or Complete)''' | ||
+ | !'''Date Completed by Author''' | ||
+ | !'''Associate Editor''' | ||
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
|- | |- | ||
|Ductal adenoma||Disease|| | |Ductal adenoma||Disease|| | ||
Line 211: | Line 223: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | !'''Disease''' | ||
+ | !'''Page Type''' | ||
+ | !'''<span style="color:#0070C0">Author''' | ||
+ | !'''Date Assigned to Author''' | ||
+ | !'''Target Completion Date''' | ||
+ | !'''Author Content (Pending or Complete)''' | ||
+ | !'''Date Completed by Author''' | ||
+ | !'''Associate Editor''' | ||
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
|- | |- | ||
|Lobular carcinoma in situ||Disease|| | |Lobular carcinoma in situ||Disease|| | ||
Line 301: | Line 324: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | !'''Disease''' | ||
+ | !'''Page Type''' | ||
+ | !'''<span style="color:#0070C0">Author''' | ||
+ | !'''Date Assigned to Author''' | ||
+ | !'''Target Completion Date''' | ||
+ | !'''Author Content (Pending or Complete)''' | ||
+ | !'''Date Completed by Author''' | ||
+ | !'''Associate Editor''' | ||
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
|- | |- | ||
|Carcinoma with apocrine differentiation||Disease|| | |Carcinoma with apocrine differentiation||Disease|| | ||
Line 392: | Line 426: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST) | + | !'''Disease''' |
+ | !'''Page Type''' | ||
+ | !'''<span style="color:#0070C0">Author''' | ||
+ | !'''Date Assigned to Author''' | ||
+ | !'''Target Completion Date''' | ||
+ | !'''Author Content (Pending or Complete)''' | ||
+ | !'''Date Completed by Author''' | ||
+ | !'''Associate Editor''' | ||
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
+ | |- | ||
+ | | | ||
+ | ====CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST)==== | ||
| | | | ||
---- | ---- | ||
Line 439: | Line 485: | ||
|2021 template added | |2021 template added | ||
|- | |- | ||
− | |CHAPTER 4 (TUMOURS OF THE NIPPLE) | + | | |
+ | ====CHAPTER 4 (TUMOURS OF THE NIPPLE)==== | ||
| | | | ||
---- | ---- | ||
Line 486: | Line 533: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST) | + | | |
+ | ====CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST)==== | ||
| | | | ||
---- | ---- | ||
Line 514: | Line 562: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | !'''Disease''' | ||
+ | !'''Page Type''' | ||
+ | !'''<span style="color:#0070C0">Author''' | ||
+ | !'''Date Assigned to Author''' | ||
+ | !'''Target Completion Date''' | ||
+ | !'''Author Content (Pending or Complete)''' | ||
+ | !'''Date Completed by Author''' | ||
+ | !'''Associate Editor''' | ||
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
|- | |- | ||
|Angiomatosis||Disease|| | |Angiomatosis||Disease|| | ||
Line 604: | Line 663: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | !'''Disease''' | ||
+ | !'''Page Type''' | ||
+ | !'''<span style="color:#0070C0">Author''' | ||
+ | !'''Date Assigned to Author''' | ||
+ | !'''Target Completion Date''' | ||
+ | !'''Author Content (Pending or Complete)''' | ||
+ | !'''Date Completed by Author''' | ||
+ | !'''Associate Editor''' | ||
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
|- | |- | ||
|Granular cell tumour||Disease|| | |Granular cell tumour||Disease|| | ||
Line 668: | Line 738: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST) | + | | |
+ | ====CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST)==== | ||
| | | | ||
---- | ---- | ||
Line 705: | Line 776: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | !'''Disease''' | ||
+ | !'''Page Type''' | ||
+ | !'''<span style="color:#0070C0">Author''' | ||
+ | !'''Date Assigned to Author''' | ||
+ | !'''Target Completion Date''' | ||
+ | !'''Author Content (Pending or Complete)''' | ||
+ | !'''Date Completed by Author''' | ||
+ | !'''Associate Editor''' | ||
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
|- | |- | ||
|Diffuse large B-cell lymphoma||Disease|| | |Diffuse large B-cell lymphoma||Disease|| | ||
Line 733: | Line 815: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 7 (TUMOURS OF THE MALE BREAST) | + | | |
+ | ====CHAPTER 7 (TUMOURS OF THE MALE BREAST)==== | ||
| | | | ||
---- | ---- | ||
Line 789: | Line 872: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST) | + | | |
+ | ====CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST)==== | ||
| | | | ||
---- | ---- | ||
Line 818: | Line 902: | ||
|N/A | |N/A | ||
|- | |- | ||
− | + | !'''Disease''' | |
− | + | !'''Page Type''' | |
− | + | !'''<span style="color:#0070C0">Author''' | |
− | + | !'''Date Assigned to Author''' | |
− | + | !'''Target Completion Date''' | |
− | + | !'''Author Content (Pending or Complete)''' | |
− | | | + | !'''Date Completed by Author''' |
− | | | + | !'''Associate Editor''' |
+ | !'''Date of Last Editor Review''' | ||
+ | !'''Notes''' | ||
+ | |- | ||
+ | |[[BRST5:Cowden syndrome|Cowden syndrome]]||Disease||[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | |[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
Line 881: | Line 976: | ||
|N/A | |N/A | ||
|- | |- | ||
− | | | + | |[[GTS5:Neurofibromatosis type 1 (NF1)|Neurofibromatosis type 1]]||Disease||[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | + | |N/A | |
− | + | |N/A | |
− | + | |N/A | |
− | + | |N/A | |
− | + | |N/A | |
− | + | |N/A | |
− | + | |N/A | |
|- | |- | ||
|[[BRST5:Polygenic component of breast cancer susceptibility|Polygenic component of breast cancer susceptibility]] | |[[BRST5:Polygenic component of breast cancer susceptibility|Polygenic component of breast cancer susceptibility]] |
Latest revision as of 13:52, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
---|---|---|---|---|---|---|---|---|---|
CHAPTER 2 (EPITHELIAL TUMOURS OF THE BREAST) |
|
|
|
|
|
|
|
|
|
Usual ductal hyperplasia | Disease | ||||||||
Columnar cell lesions, including flat epithelial atypia | Disease | ||||||||
Atypical ductal hyperplasia | Disease | ||||||||
Sclerosing adenosis | Disease | ||||||||
Apocrine adenosis and adenoma | Disease | ||||||||
Microglandular adenosis | Disease | ||||||||
Radial scar/complex sclerosing lesion | Disease | ||||||||
Tubular adenoma | Disease | ||||||||
Lactating adenoma | Disease | ||||||||
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
Ductal adenoma | Disease | ||||||||
Pleomorphic adenoma | Disease | ||||||||
Adenomyoepithelioma | Disease | ||||||||
Malignant adenomyoepithelioma | Disease | ||||||||
Intraductal papilloma | Disease | ||||||||
Papillary ductal carcinoma in situ | Disease | ||||||||
Encapsulated papillary carcinoma | Disease | ||||||||
Solid papillary carcinoma (in situ and invasive) | Disease | ||||||||
Invasive papillary carcinoma | Disease | ||||||||
Atypical lobular hyperplasia | Disease | ||||||||
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
Lobular carcinoma in situ | Disease | ||||||||
Ductal carcinoma in situ | Disease | ||||||||
Invasive breast carcinoma of no special type | Disease | ||||||||
Microinvasive carcinoma | Disease | ||||||||
Invasive lobular carcinoma | Disease | ||||||||
Tubular carcinoma | Disease | ||||||||
Cribriform carcinoma | Disease | ||||||||
Mucinous carcinoma | Disease | ||||||||
Mucinous cystadenocarcinoma | Disease | ||||||||
Invasive micropapillary carcinoma | Disease | ||||||||
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
Carcinoma with apocrine differentiation | Disease | ||||||||
Metaplastic carcinoma | Disease | ||||||||
Acinic cell carcinoma | Disease | Patricija Zot | 2/28/2024 | PENDING | Katherine Geiersbach | ||||
Adenoid cystic carcinoma | Disease | Katherine Geiersbach / Jun Liao | 10/12/02022 | 11/11/2023 | COMPLETE | Hui Chen / Katherine Geiersbach | 12/6/2023 | 2021 template added | |
Secretory carcinoma | Disease | Hui Chen / Morteza Seifi | 10/12/2022 | 11/11/2023 | COMPLETE | Katherine Geiersbach | 2021 template added | ||
Mucoepidermoid carcinoma | Disease | ||||||||
Polymorphous adenocarcinoma | Disease | ||||||||
Tall cell carcinoma with reversed polarity | Disease | H. Evin Gulbahce | 8/11/2023 | 10/11/2023 | COMPLETE | Katherine Geiersbach | 2021 template added | ||
Neuroendocrine tumour | Disease | ||||||||
Neuroendocrine carcinoma | Disease | ||||||||
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
CHAPTER 3 (FIBROEPITHELIAL TUMOURS AND HAMARTOMAS OF THE BREAST) |
|
|
|
|
|
|
|
|
|
Hamartoma | Disease | ||||||||
Fibroadenoma | Disease | H. Evin Gulbahce / Patricija Zot | 8/11/2023 | 11/11/2023 | PENDING | 2021 template added | |||
Phyllodes tumour | Disease | Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach | 8/11/2023 | 11/11/2023 | COMPLETE | 2021 template added | |||
CHAPTER 4 (TUMOURS OF THE NIPPLE) |
|
|
|
|
|
|
|
|
|
Syringomatous tumour | Disease | ||||||||
Nipple adenoma | Disease | ||||||||
Paget disease of the breast | Disease | ||||||||
CHAPTER 5 (MESENCHYMAL TUMOURS OF THE BREAST) |
|
|
|
|
|
|
|
|
|
Haemangioma | Disease | ||||||||
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
Angiomatosis | Disease | ||||||||
Atypical vascular lesions | Disease | ||||||||
Postradiation angiosarcoma of the breast | Disease | ||||||||
Primary angiosarcoma of the breast | Disease | ||||||||
Nodular fasciitis | Disease | ||||||||
Myofibroblastoma | Disease | ||||||||
Desmoid fibromatosis | Disease | ||||||||
Inflammatory myofibroblastic tumour | Disease | Yajuan Liu | 8/11/2023 | 11/11/2023 | COMPLETE | Katherine Geiersbach | 12/6/2023 | 2021 template added | |
Schwannoma | Disease | ||||||||
Neurofibroma | Disease | ||||||||
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
Granular cell tumour | Disease | ||||||||
Leiomyoma | Disease | ||||||||
Leiomyosarcoma | Disease | ||||||||
Lipoma | Disease | ||||||||
Angiolipoma | Disease | ||||||||
Liposarcoma | Disease | ||||||||
Pseudoangiomatous stromal hyperplasia | Disease | ||||||||
CHAPTER 6 (HAEMATOLYMPHOID TUMOURS OF THE BREAST) |
|
|
|
|
|
|
|
|
|
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | Disease | ||||||||
Follicular lymphoma | Disease | ||||||||
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
Diffuse large B-cell lymphoma | Disease | ||||||||
Burkitt lymphoma | Disease | ||||||||
Breast implant-associated anaplastic large cell lymphoma | Disease | ||||||||
CHAPTER 7 (TUMOURS OF THE MALE BREAST) |
|
|
|
|
|
|
|
|
|
Gynaecomastia | Disease | ||||||||
Carcinoma in situ | Disease | ||||||||
Invasive carcinoma | Disease | ||||||||
Metastases to the breast | Disease | ||||||||
CHAPTER 8 (GENETIC TUMOUR SYNDROMES OF THE BREAST) |
|
|
|
|
|
|
|
|
|
BRCA1/2-associated hereditary breast and ovarian cancer syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Disease | Page Type | Author | Date Assigned to Author | Target Completion Date | Author Content (Pending or Complete) | Date Completed by Author | Associate Editor | Date of Last Editor Review | Notes |
Cowden syndrome | Disease | See DIG5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Ataxia-telangiectasia | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Li-Fraumeni syndrome, TP53-associated | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Li-Fraumeni syndrome, CHEK2-associated | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CDH1-associated breast cancer | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
PALB2-associated cancers | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Peutz-Jeghers syndrome | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Neurofibromatosis type 1 | Disease | See GTS5 volunteer sheet for authorship status | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Polygenic component of breast cancer susceptibility | Disease | Xiaolin Hu | 6/4/2024 | Template added (6/4/24) |